Market Forecast by Countries (Germany, United Kingdom, France, Italy, Russia, Spain, Rest of Europe), By Type (Porcine Vaccines, Poultry Vaccine, Livestock Vaccine, Companion Animal Vaccine, Aquaculture Vaccines, Other Animal Vaccines), By Disease (Porcine, Poultry, Livestock, Companion Animal, Aquaculture), By Technology (Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Other Vaccines) And Competitive Landscape
Product Code: ETC078554 | Publication Date: Aug 2021 | Updated Date: Apr 2024 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 200 | No. of Figures: 90 | No. of Tables: 30 | |
Report Name | Europe Veterinary Vaccines Market |
Forecast period | 2024-2030 |
CAGR | 5.8% |
Growing Sector | Animal and Livestock |
Europe Veterinary Vaccines Market report thoroughly covers the market by countries, by type, by disease, and by technology. The market outlook report provides an unbiased and detailed analysis of the ongoing market trends, opportunities/high growth areas, and market drivers which would help the stakeholders to devise and align their market strategies according to the current and future market dynamics.
The veterinary vaccines market in Europe is observed to be rapidly evolving, driven by an increasing awareness of animal health and the significant economic consequences of livestock diseases. Vaccination plays a crucial role in protecting animals from a range of infectious diseases, contributing to the sustainability of livestock production and the safety of foods of animal origin. Technological advancements in biotechnology have led to the development of more efficient and safer vaccines, further propelling the market's growth.
According to 6Wresearch, the Europe Veterinary Vaccines Market size is estimated to reach at a CAGR of 5.8% during the forecast period 2024-2030. Key drivers of the veterinary vaccines market in Europe include the rising ownership of companion animals, growing livestock production demands, and strict government regulations regarding animal health. The advent of new vaccine technologies, such as DNA vaccines and recombinant vaccines, provides enhanced efficacy and safety, appealing to a broader range of applications in animal health management. Emerging trends in the Europe Veterinary Vaccines industry include a growing focus on zoonotic diseases, which impact both animals and humans, emphasizing the need for "One Health" approaches to vaccine development. There is also a rising demand for vaccines that offer longer immunity periods, reducing the need for frequent revaccination. The market is witnessing a shift towards more personalized vaccine protocols, tailored to the specific needs and health status of individual animals or herds, aligning with precision medicine principles.
European governments have introduced various initiatives aimed at enhancing animal health and welfare, comprehensively supporting the veterinary vaccines market. Notably, the European Union's Animal Health Law (AHL) represents a significant legislative effort to strengthen disease prevention and control across all EU member states. This law consolidates numerous existing regulations into a cohesive framework, focusing on vaccination as a key preventive measure. Additionally, the EUโs financial support for research in animal health, through programs like Horizon 2020, encourages innovation in vaccine development, ensuring the sector remains at the cutting edge of scientific advances.
The European veterinary vaccines market is characterized by the presence of several key players, contributing to its growth and dynamism. Leading companies such as Zoetis, Merck Animal Health, and Boehringer Ingelheim play pivotal roles in the development and distribution of vaccines across the continent.
The Europe veterinary vaccines market growth is set to continue to expand, driven by increasing awareness of animal health and welfare, ongoing advancements in vaccine technology, and sustained government support. Innovations such as mRNA vaccine technologies and nanoparticle vaccines are expected to revolutionize the field, offering enhanced safety profiles and efficacy rates. Additionally, the evolving nature of animal diseases and the global challenge of antimicrobial resistance (AMR) underscore the critical importance of vaccines in maintaining animal and public health.
According to Shivankar, Research Manager, 6Wresearch, Germany leads the veterinary vaccines market, attributed to its robust animal health infrastructure, significant investments in research and development, and advanced technological implementations in vaccine production.
Based on the technology, Live Attenuated Vaccines are dominating the Europe Veterinary Vaccines Market revenue, influenced by this technology involves the use of viruses or bacteria that have been modified so they can no longer cause disease but still elicit a strong immune response when administered to the animal. Their ability to mimic natural infection closely results in long-lasting immunity, often achieved with a single dose.
The report offers a comprehensive study of the subsequent market segments:
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Europe Veterinary Vaccines Market Overview |
3.1 Europe Regional Macro Economic Indicators |
3.2 Europe Veterinary Vaccines Market Revenues & Volume, 2020 & 2030F |
3.3 Europe Veterinary Vaccines Market - Industry Life Cycle |
3.4 Europe Veterinary Vaccines Market - Porter's Five Forces |
3.5 Europe Veterinary Vaccines Market Revenues & Volume Share, By Countries, 2020 & 2030F |
3.6 Europe Veterinary Vaccines Market Revenues & Volume Share, By Type, 2020 & 2030F |
3.7 Europe Veterinary Vaccines Market Revenues & Volume Share, By Disease, 2020 & 2030F |
3.8 Europe Veterinary Vaccines Market Revenues & Volume Share, By Technology, 2020 & 2030F |
4 Europe Veterinary Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Europe Veterinary Vaccines Market Trends |
6 Europe Veterinary Vaccines Market, 2020 - 2030 |
6.1 Europe Veterinary Vaccines Market, Revenues & Volume, By Type, 2020 - 2030 |
6.2 Europe Veterinary Vaccines Market, Revenues & Volume, By Disease, 2020 - 2030 |
6.3 Europe Veterinary Vaccines Market, Revenues & Volume, By Technology, 2020 - 2030 |
7 Germany Veterinary Vaccines Market, 2020 - 2030 |
7.1 Germany Veterinary Vaccines Market, Revenues & Volume, By Type, 2020 - 2030 |
7.2 Germany Veterinary Vaccines Market, Revenues & Volume, By Disease, 2020 - 2030 |
7.3 Germany Veterinary Vaccines Market, Revenues & Volume, By Technology, 2020 - 2030 |
8 United Kingdom Veterinary Vaccines Market, 2020 - 2030 |
8.1 United Kingdom Veterinary Vaccines Market, Revenues & Volume, By Type, 2020 - 2030 |
8.2 United Kingdom Veterinary Vaccines Market, Revenues & Volume, By Disease, 2020 - 2030 |
8.3 United Kingdom Veterinary Vaccines Market, Revenues & Volume, By Technology, 2020 - 2030 |
9 France Veterinary Vaccines Market, 2020 - 2030 |
9.1 France Veterinary Vaccines Market, Revenues & Volume, By Type, 2020 - 2030 |
9.2 France Veterinary Vaccines Market, Revenues & Volume, By Disease, 2020 - 2030 |
9.3 France Veterinary Vaccines Market, Revenues & Volume, By Technology, 2020 - 2030 |
10 Italy Veterinary Vaccines Market, 2020 - 2030 |
10.1 Italy Veterinary Vaccines Market, Revenues & Volume, By Type, 2020 - 2030 |
10.2 Italy Veterinary Vaccines Market, Revenues & Volume, By Disease, 2020 - 2030 |
10.3 Italy Veterinary Vaccines Market, Revenues & Volume, By Technology, 2020 - 2030 |
11 Russia Veterinary Vaccines Market, 2020 - 2030 |
11.1 Russia Veterinary Vaccines Market, Revenues & Volume, By Type, 2020 - 2030 |
11.2 Russia Veterinary Vaccines Market, Revenues & Volume, By Disease, 2020 - 2030 |
11.3 Russia Veterinary Vaccines Market, Revenues & Volume, By Technology, 2020 - 2030 |
12 Spain Veterinary Vaccines Market, 2020 - 2030 |
12.1 Spain Veterinary Vaccines Market, Revenues & Volume, By Type, 2020 - 2030 |
12.2 Spain Veterinary Vaccines Market, Revenues & Volume, By Disease, 2020 - 2030 |
12.3 Spain Veterinary Vaccines Market, Revenues & Volume, By Technology, 2020 - 2030 |
13 Rest of Europe Veterinary Vaccines Market, 2020 - 2030 |
13.1 Rest of Europe Veterinary Vaccines Market, Revenues & Volume, By Type, 2020 - 2030 |
13.2 Rest of Europe Veterinary Vaccines Market, Revenues & Volume, By Disease, 2020 - 2030 |
13.3 Rest of Europe Veterinary Vaccines Market, Revenues & Volume, By Technology, 2020 - 2030 |
14 Europe Veterinary Vaccines Market Key Performance Indicators |
15 Europe Veterinary Vaccines Market - Opportunity Assessment |
15.1 Europe Veterinary Vaccines Market Opportunity Assessment, By Countries, 2020 & 2030F |
15.2 Europe Veterinary Vaccines Market Opportunity Assessment, By Type, 2020 & 2030F |
15.3 Europe Veterinary Vaccines Market Opportunity Assessment, By Disease, 2020 & 2030F |
15.4 Europe Veterinary Vaccines Market Opportunity Assessment, By Technology, 2020 & 2030F |
16 Europe Veterinary Vaccines Market - Competitive Landscape |
16.1 Europe Veterinary Vaccines Market Revenue Share, By Companies, 2023 |
16.2 Europe Veterinary Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Company Profiles |
18 Recommendations |
19 Disclaimer |